期刊文献+

桂中地区原发性肉碱缺乏症基因测序精准检测及研究 被引量:2

Precision testing and research of primary carnitine deficiency in Central Guangxi
原文传递
导出
摘要 目的通过对桂中地区原发性肉碱缺乏症分子基因测序结果分析,研究该地区原发性肉碱缺乏症的发生率及基因突变类型,为临床提供诊疗依据。方法通过检测分析新生儿疾病筛查40168例串联质谱结果,对疑似原发性肉碱缺乏症对象,进一步应用测序手段对SLC22A5基因进行检测确诊。结果确诊13例患儿10种突变类型,包括10例PCD患者,杂合突变携带者3例。其中不乏新发突变类型。结论原发性肉碱缺乏症在桂中地区存在较高发生率以及多种突变类型,通过基因分子精准检测,为临床提供更准确实验室依据及疾病诊疗方向。 Objective:Research the incidence of primary carnitine deficiency and the types of gene mutations in primary area of carnitine deficiency in Central Guangxi,and to provide evidence for clinical diagnosis and treatment. Methods:Through the detection and analysis of 40168 cases of neonatal screening for SLC22 A5,the suspected primary carnitine deficiency subjects were further diagnosed by sequencing. Results:There were 10 types of mutation in 13 cases,including 10 PCD patients and 3 heterozygous carriers. There are no lack of new mutation types. Conclusion:Primary carnitine deficiency has high incidence and multiple mutation types in this area. It can provide more accurate laboratory evidence and disease diagnosis and treatment direction for clinic by precise detection of gene molecules.
作者 陈大宇 谭建强 杨金玲 严提珍 蔡稔 CHEN Da-yu;TAN Jian-qiang;YANG Jin-ling;YAN Ti-zhen;CAI Ren.(Department of Medical Genetics, Liuzhou Maternal and Child Health Care Hospital, Liuzhou, Guangxi545001, China)
出处 《中国优生与遗传杂志》 2018年第6期13-14,共2页 Chinese Journal of Birth Health & Heredity
基金 柳州市科学研究与技术开发计划项目研究成果资助(2014G020404) 广西壮族自治区卫计委项目(Z2016547)
关键词 原发性 肉碱缺乏症 新生儿 SLC22A5基因 Primary Carnitinedeficiency Newborns SLC22A5gene
  • 相关文献

参考文献4

二级参考文献58

  • 1顾学范,韩连书,高晓岚,杨艳玲,叶军,邱文娟.串联质谱技术在遗传性代谢病高危儿童筛查中的初步应用[J].中华儿科杂志,2004,42(6):401-404. 被引量:142
  • 2韩连书,高晓岚,叶军,邱文娟,顾学范.串联质谱分析干血滤纸片酰基肉碱方法的建立[J].中华检验医学杂志,2005,28(1):88-91. 被引量:31
  • 3Lindner M, Gramer G, Haege G, et al. Efficacy and outcome of expanded newborn screening for metabolic diseases--report of 10 years from South-West Germany. Orphanet J Rare Dis,20! 1,6:44- 53.
  • 4Longo N, Amat di San Filippo C, Pasquali M. Disorders of carnitine transport and the carnitine cycle. Am J Med Genet C Semin Med Genet,2006,142C :77-85.
  • 5Flanagan JL, Simmons PA, Vehige J, et al. Role of carnitine in disease. Nutr Metab (Lond) ,2010,7 : 3043.
  • 6Crill CM, Helms RA. The use of carnitine in pediatric nutrition. Nutr Clin Pract ,2007,22:204-213.
  • 7Amat di San Filippo C, Pasquali M, Longo N. Pharmacological rescue of carnitinc transport in primary carnitine deficiency. Hum Murat, 2006,27 : 513 -523.
  • 8Amat di San Filippo C, Taylor MR, Mestroni L, et al.Cardiomyopathy and carnitine deficiency. Mol Genet Metab,2008, 94 : 162-166.
  • 9Yamak AA, Bitar F, Karam P, et al. Exclusive cardiac dysfunction in familial primary camitine deficiency cases: a genotype-phenotype correlation. Clin Genet, 2007,72 : 59 -62.
  • 10Lund AM, Joensen F, Hougaard DM, et al. Carnitine transporter and holocarboxylase synthetase deficiencies in The Faroe Islands. J Inherit Metab Dis,2007,30:341-349.

共引文献55

同被引文献15

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部